Medicines Act 1981

Dealings with medicines and medical devices - Approval of medicines required for use in special emergency

24D: Approval of medicines required for use in special emergency

You could also call this:

"Getting permission to use a medicine in a special emergency"

Illustration for Medicines Act 1981

You can ask the Minister for approval to distribute, sell, or advertise a medicine in a special emergency. The Minister can approve this if they are satisfied that there is a special emergency, the medicine is needed for it, and the application is correct. You must pay a fee and give the Minister the information they need to make a decision, as stated in the application form approved by the Director-General.

This text is automatically generated. It might be out of date or be missing some parts. Find out more about how we do this.

This page was last updated on

View the original legislation for this page at https://legislation.govt.nz/act/public/1986/0120/latest/link.aspx?id=DLM55408.


Previous

24C: Interpretation, or

"What special words mean in the Medicines Act"


Next

24E: Notification or publication of approval, or

"Telling the public when a new medicine is approved"

Part 2Dealings with medicines and medical devices
Approval of medicines required for use in special emergency

24DApproval of medicines required for use in special emergency

  1. An application may be made to the Minister for approval to distribute, sell, or advertise in a special emergency a medicine that is or contains a hazardous substance or new organism.

  2. The Minister may approve an application under subsection (1) with or without conditions, as long as the Minister is satisfied that—

  3. the special emergency has been declared and has not come to an end; and
    1. the medicine is required for the special emergency; and
      1. the application complies with subsection (3).
        1. An application under subsection (1) must—

        2. be accompanied by the prescribed application fee (if any); and
          1. be in a form approved by the Director-General; and
            1. be accompanied by any information that the Minister considers is necessary for determining whether or not to approve the application.
              Notes
              • Section 24D: inserted, on , by section 5 of the Medicines Amendment Act (No 2) 2003 (2003 No 56).